What bothers me isn't the price of drugs, it's the rage.
Nathan Smith discusses the public's reaction to Daraprim's price rise on NBR Radio and on demand on MyNBR Radio.
Fri, 25 Sep 2015
Some obscure CEO of a peripheral drug company decides to arbitrarily raise the price of a product by 5000% and everybody on the internet flips out. Normal day on the worldwide web? Not really.
Martin Shkreli is the chief executive of Turing Pharmaceuticals, a company internationally condemned for
Want to read more? It's easy.
Choose your best value subscription option
Student
Exclusive offer for uni students studying at a New Zealand university (valued at $499).